CLEAR Trial: Is Lenvatinib Plus Pembrolizumab the Best First-Line Immunotherapy Doublet in Metastatic Renal Cell Carcinoma? - The ASCO Post
Accuracy of detecting residual disease after neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma (preSINO trial): a prospective multicenter diagnostic cohort study | BMC Cancer | Full Text
CROSS Trial: Esophageal Cancer, Surgery, and Neoadjuvant Therapy | BTK/RAS-ACS Journal Club #9 - YouTube
Cross trial esophagus updated result
CRITICS II study protocol (Gastric Cancer) | Digestive Disease Dashboard
Frontiers | Neoadjuvant Chemoradiotherapy and Surgery for Esophageal Squamous Cell Carcinoma Versus Definitive Chemoradiotherapy With Salvage Surgery as Needed: The Study Protocol for the Randomized Controlled NEEDS Trial
Cross trial
Journal of Clinical Oncology on Twitter: "Survival benefit of preoperative chemoradiotherapy for patients with esophageal cancer persists - 10-year outcome of the CROSS trial https://t.co/s02sMVpYhI #esocsm #JCO @ErasmusMC @bmeyck https://t.co ...
Real-world Scenario: CROSS Regimen as Preoperative Therapy for Oesophageal Squamous Cell Carcinoma | SpringerLink
ICORG 10-14: NEOadjuvant trial in Adenocarcinoma of the oEsophagus and oesophagoGastric junction International Study (Neo-AEGIS) | BMC Cancer | Full Text
Types of Trial Design: Cross-over Trial Design
Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer | NEJM
Modification of preoperative radiochemotherapy for esophageal cancer (CROSS protocol) is safe and efficient with no impact on surgical morbidity | SpringerLink
Alex Cross's Trial - Wikipedia
Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial | Journal of Clinical Oncology
![PDF] Accuracy of Detecting Residual Disease After Cross Neoadjuvant Chemoradiotherapy for Esophageal Cancer (preSANO Trial): Rationale and Protocol | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/630bc6b873bf8304e24a6ac1260e289c3deac5d2/8-Figure2-1.png "PDF] Accuracy of Detecting Residual Disease After Cross Neoadjuvant Chemoradiotherapy for Esophageal Cancer (preSANO Trial): Rationale and Protocol | Semantic Scholar")
PDF] Accuracy of Detecting Residual Disease After Cross Neoadjuvant Chemoradiotherapy for Esophageal Cancer (preSANO Trial): Rationale and Protocol | Semantic Scholar
![PDF] Cross-trial prediction of treatment outcome in depression: a machine learning approach. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/6194c942b91634e8b7c340f158ba759b0789ca7d/5-Figure2-1.png "PDF] Cross-trial prediction of treatment outcome in depression: a machine learning approach. | Semantic Scholar")
PDF] Cross-trial prediction of treatment outcome in depression: a machine learning approach. | Semantic Scholar
Cross trial esophagus updated result
Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer | NEJM
Preoperative Chemoradiation in Carcinoma Esophagus: Experience from a Tertiary Cancer Center in India
Summary of the CROSS phase III randomized trial that assessed the role... | Download Table
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial - The Lancet Oncology
Neoadjuvant treatment strategy for locally advanced thoracic esophageal cancer - Mayanagi - 2019 - Annals of Gastroenterological Surgery - Wiley Online Library
Esophageal Cancer Updates. - ppt download
